Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Aleksandra, Rękorajska"'
Autor:
Dorota Nieciecka, Aleksandra Rękorajska, Dariusz Cichy, Paulina Końska, Michał Żuk, Paweł Krysiński
Publikováno v:
Nanomaterials, Vol 12, Iss 5, p 795 (2022)
The study aimed to synthesize and characterize the magnetic drug carrier modified with terbium (III) ions. The addition of terbium extends the possibilities of their applications for targeted anticancer radiotherapy as well as for imaging techniques
Externí odkaz:
https://doaj.org/article/2042d24f5961499fb80b6a87446fc9e8
Autor:
Dorota, Nieciecka, Aleksandra, Rękorajska, Dariusz, Cichy, Paulina, Końska, Michał, Żuk, Paweł, Krysiński
Publikováno v:
Nanomaterials (Basel, Switzerland). 12(5)
The study aimed to synthesize and characterize the magnetic drug carrier modified with terbium (III) ions. The addition of terbium extends the possibilities of their applications for targeted anticancer radiotherapy as well as for imaging techniques
Publikováno v:
Journal of Magnetism and Magnetic Materials. 479:50-58
A large range of nanoscale superparamagnetic materials has been under scrutiny from the point of view of their potential theranostic, multimodal applications. In this paper we have investigated the effect of replacing Fe3+ cations with Gd3+ and Tb3+
Publikováno v:
Electrochemistry Communications, Vol 93, Iss, Pp 66-70 (2018)
We present electrochemical evidence that magnetic interactions between the paramagnetic heme centers of fructose dehydrogenase subunit II and superparamagnetic iron oxide nanoparticles enable a suitable orientation of the enzyme molecule and enhance
Autor:
Gary J. Blanchard, Michał K. Cyrański, Paweł Krysiński, Grzegorz Cichowicz, Aleksandra Rękorajska, M. Grdeń, Marek Pękała
Publikováno v:
ChemNanoMat. 4:231-242
Autor:
Michał Chudy, Aleksandra Szuplewska, Aleksandra Rękorajska, Artur Dybko, Edyta Pocztańska, Paweł Krysiński
Publikováno v:
Nanotechnology. 30(31)
Magnetoliposomes are promising candidates for the development of selective drug delivery systems in the treatment of cancer. Those nanosystems were tested as carriers of a strong chemotherapeutic agent, doxorubicin, which is used against breast cance
Autor:
Aleksandra Szuplewska, Aleksandra Rękorajska (Joniec), Edyta Pocztańska, Paweł Krysiński, Artur Dybko, Michał Chudy
Publikováno v:
Nanotechnology; 8/2/2019, Vol. 30 Issue 31, p1-1, 1p